表纸
市场调查报告书

类鸦片物质药的全球市场的未来预测 (2019~2028年)

Global Opioids Drugs Market Forecast 2019-2028

出版商 Inkwood Research 商品编码 750061
出版日期 内容资讯 英文 168 Pages
商品交期: 2-3个工作天内
价格
类鸦片物质药的全球市场的未来预测 (2019~2028年) Global Opioids Drugs Market Forecast 2019-2028
出版日期: 2020年05月11日内容资讯: 英文 168 Pages
简介

全球类鸦片物质药市场在2019年~2028年间,预测将以2.48%的年复合成长率成长。作为市场成长的主要的促进因素,是由于交通事故和外科治疗增加,重病患者的缓和照护的利用扩大,慢性疼痛的发病数量的增加,还有滥用防止制剂 (ADF)的开发以防止滥用、误用、中毒等。

本报告提供全球类鸦片物质药市场未来展望相关分析,产品概要和市场结构,主要的推动及阻碍市场要素,整体市场规模趋势预测 (今后9年份),各产品、各用途及各地区详细趋势,市场竞争环境,主要企业简介等调查。

第1章 分析范围、手法

第2章 摘要整理

第3章 市场动态

  • 母体市场分析:软体市场
  • 市场定义
  • 主要的推动市场要素
    • 交通事故的增加与外科治疗
    • 重度患者的缓和照护的逐步上升
    • 为了限制类鸦片物质滥用使用滥用抑制制剂 (ADF)
    • 慢性疼痛的发生数量增加
  • 主要的阻碍市场要素
    • 类鸦片物质的误用
    • 严格的法律规范
    • 地球整体的类鸦片物质危机
    • 对类鸦片物质制造商的诉讼案例增加
    • 类鸦片物质的过量摄取相关死亡的增加

第4章 主要分析

  • 主要投资的考察
  • 波特的五力分析
  • 市场机会矩阵
  • 业者情势
  • 法律规范
  • 开发平台分析
  • 类鸦片物质药市场上的产业趋势
  • 技术进步

第5章 各产品的市场

  • Buprenornhine
  • Fentanyl
  • HYDROCODONE
  • 吗啡
  • OXYCODONE
  • Tramadol
  • 其他的产品

第6章 各用途市场

  • 疼痛缓和
    • 癌症疼痛
    • 手术后疼痛管理
    • 腰痛
    • 整形外科
    • 纤维肌痛症
    • 神经病变
  • 麻醉
  • 止咳药
  • 腹泻抑制
  • 成瘾治疗

第7章 各地区分析

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 俄罗斯
    • 比利时
    • 波兰
    • 其他欧洲各国
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 印尼
    • 泰国
    • 越南
    • 澳洲、纽西兰
    • 其他的亚太地区各国
  • 其他的国家 (RoW)
    • 南美
    • 中东、非洲

第8章 企业简介

  • ACURA PHARMACEUTICALS INC
  • ALLERGAN PLC
  • BIODELIVERY SCIENCES INTERNATIONAL INC
  • CIPHER PHARMACEUTICALS INC
  • COLLEGIUM PHARMACEUTICAL INC
  • 第一三共
  • EGALET CORP
  • HIKMA PHARMACEUTICALS PLC
  • INDIVIOR INC
  • JANSSEN PHARMACEUTICALS INC
  • JOHNSON & JOHNSON
  • LANNETT CO. INC
  • LUPIN LTD
  • MYLAN NV
  • PFIZER INC
  • PURDUE PHARMA LP
  • SANOFI-AVENTIS SA
  • SUN PHARMACEUTICAL INDUSTRIES LIMITED(SUN PHARMA)
  • TEVA PHARMACEUTICAL INDUSTRIES LTD

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: 22680

KEY FINDINGS

The global opioids drugs market is anticipated to grow at a CAGR of 2.48% over the forecast period of 2019-2028. The major factors augmenting the global market growth are the growing number of road accidents and surgical procedures, increasing palliative care for patients going through intense suffering, and growing incidence of chronic pain.

MARKET INSIGHTS

Opioids are majorly used to relieve moderate to severe pain, though they can occasionally be used to treat coughing and diarrhea. The opioid drugs are associated with side effects, a high risk of dependence, and addiction. Opioid addiction, overdose, and abuse, are serious health concerns across the world. Novel opioid formulation to reduce the risk of abuse is driving the market growth. The development of abuse-deterrent formulations (ADF) of opioid medications is likely to decrease abuse, misuse, and addiction to opioid drugs. The ADF is designed in such a way that the drug becomes resistant to physical manipulation.

Opioid misuse is one of the major factors restraining market growth. Opioid misuse includes abuse of prescription pain relievers or the use of heroin. The existing market players are focusing on developing innovative dosage forms, which will increase drug efficiency at a minimum dose.

REGIONAL INSIGHTS

The global opioids drugs market has been segregated into North America, Europe, Asia Pacific, and the Rest of the World to analyze the potential of the respective markets. The region of North America holds the largest market share in terms of revenue in 2019. The high rate of approval and launch of new abuse-deterrent formulation (ADF) of the opioid drug is contributing to market growth in the region.

COMPETITIVE INSIGHTS

The market competition is high in the generic space owing to major companies supplying various opioid drugs. Some of the prominent existing players in the market are Daiichi Sankyo, Inc, Teva Pharmaceutical Industries Ltd, Hikma Pharmaceuticals, Janssen Pharmaceuticals, Inc, Lupin Ltd, Johnson & Johnson, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. INCREASING ROAD ACCIDENTS AND SURGICAL PROCEDURES
    • 3.2.2. ESCALATING PALLIATIVE CARE FOR PATIENTS SUFFERING INTENSELY
    • 3.2.3. USAGE OF ABUSE DETERRENT FORMULATIONS TO RESTRICT THE OPIOID ABUSE
    • 3.2.4. GROWING OCCURRENCE OF CHRONIC PAIN
  • 3.3. KEY RESTRAINTS
    • 3.3.1. MISUSE OF OPIOIDS
    • 3.3.2. STRINGENT REGULATORY FRAMEWORK
    • 3.3.3. OPIOID CRISIS ACROSS THE GLOBE
    • 3.3.4. INCREASING NUMBER OF LAWSUITS CASES AGAINST OPIOIDS MANUFACTURERS
    • 3.3.5. RISING OCCURRENCE OF DEATHS RELATED TO OPIOID OVERDOSE

4. KEY ANALYTICS

  • 4.1. KEY INVESTMENT INSIGHTS
  • 4.2. PORTER'S FIVE FORCE ANALYSIS
    • 4.2.1. BUYER POWER
    • 4.2.2. SUPPLIER POWER
    • 4.2.3. SUBSTITUTION
    • 4.2.4. NEW ENTRANTS
    • 4.2.5. INDUSTRY RIVALRY
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. REGULATORY FRAMEWORK
  • 4.6. PIPELINE ANALYSIS
  • 4.7. INDUSTRY EVENTS IN OPIOID DRUGS MARKET
  • 4.8. TECHNOLOGICAL ADVANCEMENT

5. MARKET BY PRODUCT

  • 5.1. BUPRENORPHINE
  • 5.2. FENTANYL
  • 5.3. HYDROCODONE
  • 5.4. MORPHINE
  • 5.5. OXYCODONE
  • 5.6. TRAMADOL
  • 5.7. OTHER PRODUCTS

6. MARKET BY APPLICATION

  • 6.1. PAIN RELIEF
    • 6.1.1. CANCER PAIN
    • 6.1.2. POSTOPERATIVE PAIN MANAGEMENT
    • 6.1.3. LOW BACK PAIN
    • 6.1.4. ORTHOPEDIC
    • 6.1.5. FIBROMYALGIA
    • 6.1.6. NEUROPATHIC
  • 6.2. ANESTHESIA
  • 6.3. COUGH SUPPRESSION
  • 6.4. DIARRHEA SUPPRESSION
  • 6.5. DEADDICTION

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. UNITED KINGDOM
    • 7.2.2. GERMANY
    • 7.2.3. FRANCE
    • 7.2.4. ITALY
    • 7.2.5. RUSSIA
    • 7.2.6. BELGIUM
    • 7.2.7. POLAND
    • 7.2.8. REST OF EUROPE
  • 7.3. ASIA PACIFIC
    • 7.3.1. CHINA
    • 7.3.2. JAPAN
    • 7.3.3. INDIA
    • 7.3.4. SOUTH KOREA
    • 7.3.5. INDONESIA
    • 7.3.6. THAILAND
    • 7.3.7. VIETNAM
    • 7.3.8. AUSTRALIA & NEW ZEALAND
    • 7.3.9. REST OF ASIA PACIFIC
  • 7.4. REST OF WORLD
    • 7.4.1. LATIN AMERICA
    • 7.4.2. MIDDLE EAST AND AFRICA

8. COMPANY PROFILES

  • 8.1. ACURA PHARMACEUTICALS INC
  • 8.2. ALLERGAN PLC
  • 8.3. BIODELIVERY SCIENCES INTERNATIONAL INC
  • 8.4. CIPHER PHARMACEUTICALS INC
  • 8.5. COLLEGIUM PHARMACEUTICAL INC
  • 8.6. DAIICHI SANKYO INC
  • 8.7. EGALET CORP
  • 8.8. HIKMA PHARMACEUTICALS PLC
  • 8.9. INDIVIOR INC
  • 8.10. JANSSEN PHARMACEUTICALS INC
  • 8.11. JOHNSON & JOHNSON
  • 8.12. LANNETT CO. INC
  • 8.13. LUPIN LTD
  • 8.14. MYLAN NV
  • 8.15. PFIZER INC
  • 8.16. PURDUE PHARMA LP
  • 8.17. SANOFI-AVENTIS S.A
  • 8.18. SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)
  • 8.19. TEVA PHARMACEUTICAL INDUSTRIES LTD

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - OPIOIDS DRUGS
  • TABLE 2: FDA APPROVED OPIOIDS WITH ADF LABELLING
  • TABLE 3: NUMBER OF LAWSUITS CASES SETTLED BY OPIOIDS MANUFACTURING COMPANIES AND PHARMACIES, 2015-2027
  • TABLE 4: LIST OF ER/LA OPIOID BRANDED DRUGS, 2017
  • TABLE 5: LIST OF ER/LA OPIOID GENERIC DRUGS, 2017
  • TABLE 6: CDC GUIDELINES ON PRESCRIBING OPIOIDS
  • TABLE 7: PIPELINE ANALYSIS OF OPIOID DRUGS
  • TABLE 8: GLOBAL OPIOIDS DRUGS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: GLOBAL OPIOIDS DRUGS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL BUPRENORPHINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 11: GLOBAL BUPRENORPHINE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL FENTANYL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 13: GLOBAL FENTANYL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL HYDROCODONE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 15: GLOBAL HYDROCODONE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL MORPHINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 17: GLOBAL MORPHINE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL OXYCODONE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 19: GLOBAL OXYCODONE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL TRAMADOL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 21: GLOBAL TRAMADOL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL OTHER PRODUCTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 23: GLOBAL OTHER PRODUCTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL OPIOIDS DRUGS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 25: GLOBAL OPIOIDS DRUGS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL PAIN RELIEF MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 27: GLOBAL PAIN RELIEF MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL PAIN RELIEF MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 29: GLOBAL PAIN RELIEF MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL CANCER PAIN MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 31: GLOBAL CANCER PAIN MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL POSTOPERATIVE PAIN MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 33: GLOBAL POSTOPERATIVE PAIN MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL LOW BACK PAIN MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 35: GLOBAL LOW BACK PAIN MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL ORTHOPEDIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 37: GLOBAL ORTHOPEDIC MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL FIBROMYALGIA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 39: GLOBAL FIBROMYALGIA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 40: GLOBAL NEUROPATHIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 41: GLOBAL NEUROPATHIC MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 42: GLOBAL ANESTHESIA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 43: GLOBAL ANESTHESIA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 44: GLOBAL COUGH SUPPRESSION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 45: GLOBAL COUGH SUPPRESSION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 46: GLOBAL DIARRHEA SUPPRESSION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 47: GLOBAL DIARRHEA SUPPRESSION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 48: GLOBAL DEADDICTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 49: GLOBAL DEADDICTION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 50: GLOBAL OPIOIDS DRUGS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 51: GLOBAL OPIOIDS DRUGS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 52: NORTH AMERICA OPIOIDS DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 53: NORTH AMERICA OPIOIDS DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 54: EUROPE OPIOIDS DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 55: EUROPE OPIOIDS DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 56: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 57: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 58: REST OF WORLD OPIOIDS DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 59: REST OF WORLD OPIOIDS DRUGS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: KEY INVESTMENT INSIGHTS
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: GLOBAL OPIOIDS DRUGS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2019
  • FIGURE 6: GLOBAL OPIOIDS DRUGS MARKET, BY BUPRENORPHINE, 2019-2028 (IN $ MILLION)
  • FIGURE 7: GLOBAL OPIOIDS DRUGS MARKET, BY FENTANYL, 2019-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL OPIOIDS DRUGS MARKET, BY HYDROCODONE, 2019-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL OPIOIDS DRUGS MARKET, BY MORPHINE, 2019-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL OPIOIDS DRUGS MARKET, BY OXYCODONE, 2019-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL OPIOIDS DRUGS MARKET, BY TRAMADOL, 2019-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL OPIOIDS DRUGS MARKET, BY OTHER PRODUCTS, 2019-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL OPIOIDS DRUGS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2019
  • FIGURE 14: GLOBAL OPIOIDS DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL OPIOIDS DRUGS MARKET, BY CANCER PAIN, 2019-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL OPIOIDS DRUGS MARKET, BY POSTOPERATIVE PAIN MANAGEMENT, 2019-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL OPIOIDS DRUGS MARKET, BY LOW BACK PAIN, 2019-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL OPIOIDS DRUGS MARKET, BY ORTHOPEDIC, 2019-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL OPIOIDS DRUGS MARKET, BY FIBROMYALGIA, 2019-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL OPIOIDS DRUGS MARKET, BY NEUROPATHIC, 2019-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL OPIOIDS DRUGS MARKET, BY ANESTHESIA, 2019-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL OPIOIDS DRUGS MARKET, BY COUGH SUPPRESSION, 2019-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL OPIOIDS DRUGS MARKET, BY DIARRHEA SUPPRESSION, 2019-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL OPIOIDS DRUGS MARKET, BY DEADDICTION, 2019-2028 (IN $ MILLION)
  • FIGURE 25: NORTH AMERICA OPIOIDS DRUGS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 26: UNITED STATES OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 27: CANADA OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 28: EUROPE OPIOIDS DRUGS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 29: UNITED KINGDOM OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 30: GERMANY OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 31: FRANCE OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 32: ITALY OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 33: RUSSIA OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 34: BELGIUM OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 35: POLAND OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 36: REST OF EUROPE OPIOIDS DRUGS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 37: ASIA PACIFIC OPIOIDS DRUGS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 38: CHINA OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 39: JAPAN OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 40: INDIA OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 41: SOUTH KOREA OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 42: INDONESIA OPIOID DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 43: THAILAND OPIOID DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 44: VIETNAM OPIOID DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 45: AUSTRALIA & NEW ZEALAND OPIOID DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 46: REST OF WORLD OPIOIDS DRUGS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 47: LATIN AMERICA OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 48: MIDDLE EAST AND AFRICA OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)